3Wildemann B, Lubberstedt M, Haas NP, et al. IGF-I and TGF-beta 1 incorporated in a poly implant coating maintain their activity over long-term storage-cell culture studies on primary human osteoblast - like cells [ J ]. Biomate rials,2004,25 (17) :3 639 -3 644.
4Ishimura T, Fujisawa M, Higuchi A, et al. Transforming growth factor-beta1 expression in early biopsy specimen predicts long-term graft function following pediatric renal transplantation[J]. Clin Transplant,2001,15 (3): 185 - 191.
6Abdel WN, Weston BS, RobertsT, et al. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy[J]. J Am Soc Nephrol,2002,13(10) :2 437 -2 445.
7Densem CG, Mutlak ASM, Pravica V, et al. A novel polymorphism of the gene encoding furin, a TGF-β1 activator, and the influence on cardiac allograft vasculopathy formation [ J ]. Transplant Immunology, 2004, 37 ( 7 ): 697 - 702.
8Citterio F, Pozzetto U, Romagnoli J, et al. Plasma levels of transforming growth factor-β1 in renal transplant recipients receiving different immunosuppressive regimens [ J ]. Transplantation Proceedings ,2004,36(3) :698 - 699.
9Amann K, Koch Ahofstetter J. Glomerulosclerosis and progression:effect of subantihypertensive doses of alpha and beta blockers [ J ]. Kidney Int, 2001,60 ( 4 ): 1 309 -1323.
10Houlihan CA,Akdeniz A,Tsalamandris C,et al. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate:effects of angiotensin receptor blockade and sodium restriction [ J ]. Diabetes Care, 2002, 25 ( 6 ): 1 072 - 1 077.
